Suzhou Bojian Biotechnology Co., Ltd. and its subsidiary Gu'an Bojian Biotechnology Co., Ltd. (collectively "Bojian Biotech") are emerging supplier of research reagents. Over the past six years, we have developed a series of cell line-derived pathology quality control materials targeting diverse markers, leveraging our proprietary paraffin block preparation process. These products are designed to support experimental studies in pathology, addressing unmet needs in pathology research. We have supplied quality control materials for multiple PQCC pathology quality control programs. Bojian Biotech is committed to delivering high-quality pathology research and workflow services to research institutions, and research laboratories, supporting precision medicine research.